435 related articles for article (PubMed ID: 9409301)
1. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
[TBL] [Abstract][Full Text] [Related]
2. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
[TBL] [Abstract][Full Text] [Related]
3. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
[TBL] [Abstract][Full Text] [Related]
4. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Van Eck M; De Winther MP; Herijgers N; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2600-6. PubMed ID: 11116059
[TBL] [Abstract][Full Text] [Related]
5. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
7. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation.
Linton MF; Atkinson JB; Fazio S
Science; 1995 Feb; 267(5200):1034-7. PubMed ID: 7863332
[TBL] [Abstract][Full Text] [Related]
8. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
Boisvert WA; Curtiss LK
J Lipid Res; 1999 May; 40(5):806-13. PubMed ID: 10224149
[TBL] [Abstract][Full Text] [Related]
9. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.
Fazio S; Babaev VR; Murray AB; Hasty AH; Carter KJ; Gleaves LA; Atkinson JB; Linton MF
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4647-52. PubMed ID: 9114045
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.
Boisvert WA; Spangenberg J; Curtiss LK
J Clin Invest; 1995 Aug; 96(2):1118-24. PubMed ID: 7635947
[TBL] [Abstract][Full Text] [Related]
11. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
12. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
[TBL] [Abstract][Full Text] [Related]
13. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E.
Sakai Y; Kim DK; Iwasa S; Liang J; Watanabe T; Onodera M; Nakauchi H
Atherosclerosis; 2002 Mar; 161(1):27-34. PubMed ID: 11882314
[TBL] [Abstract][Full Text] [Related]
15. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
Schmitz G; Assmann G; Augustin J; Dirkes-Kersting A; Brennhaüsen B; Karoff C
J Lipid Res; 1985 Mar; 26(3):316-26. PubMed ID: 3989390
[TBL] [Abstract][Full Text] [Related]
16. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis.
Van Eck M; Zimmermann R; Groot PH; Zechner R; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):E53-62. PubMed ID: 10978269
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
18. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H
J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033
[TBL] [Abstract][Full Text] [Related]
19. Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosis-susceptible and -resistant mice.
Friedman G; Ben-Yehuda A; Dabach Y; Hollander G; Babaey S; Ben-Naim M; Stein O; Stein Y
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2459-64. PubMed ID: 11073853
[TBL] [Abstract][Full Text] [Related]
20. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
